IL6 and hepatocellular carcinoma: Very recent studies on the role of JAK-STAT signaling in hepatocellular carcinoma (HCC) emphasized that members of IL-6 family of cytokines have emerged as important regulatory factors and are considered to be targets for therapeutic intervention (Lokau et al., 2019).